Therefore, we anticipated that the TSHZ2 and TSHZ3 promotersmight be hypermethylated in the non-expressor cancer cell line cells whereas in theexpressors they would be hypomethylated, as it has been demonstrated with othertumor suppressor genes [27], [28]. The gene discussed is TSHZ2; the disease is cancer.